Posts

Showing posts from November, 2019

What Blood Tests You Should Ask For Based On Your Family History - mindbodygreen.com

What Blood Tests You Should Ask For Based On Your Family History    mindbodygreen.com

Global Drugs for Rheumatoid Arthritis Market Growth Analysis, Forecasts to 2025 : AbbVie Inc, Hoffman-La Roche AG, Amgen Inc, Pfizer Inc - Industry News Archive

Global Drugs for Rheumatoid Arthritis Market Growth Analysis, Forecasts to 2025 : AbbVie Inc, Hoffman-La Roche AG, Amgen Inc, Pfizer Inc    Industry News Archive

Global Sulfasalazine Tablets Market Growth 2019-2025 – Pfizer, Teva Pharmaceuticals, Santen, Watson Labs, Vintage Pharms - Breakaway Trends

Global Sulfasalazine Tablets Market Growth 2019-2025 – Pfizer, Teva Pharmaceuticals, Santen, Watson Labs, Vintage Pharms    Breakaway Trends

Seropositive Rheumatoid Arthritis Drug Market 2019: Global Industry Insights by Global Players, Regional Segmentation, Growth, Applications, Major Drivers, Value and Foreseen till 2023 | 360 Market Updates - News Reel Hub

Seropositive Rheumatoid Arthritis Drug Market 2019: Global Industry Insights by Global Players, Regional Segmentation, Growth, Applications, Major Drivers, Value and Foreseen till 2023 | 360 Market Updates    News Reel Hub

European Commission approves subcutaneous infliximab biosimilar for RA - Healio

European Commission approves subcutaneous infliximab biosimilar for RA    Healio

Here’s How Obesity Impacts RA Treatment Efficacy - DocWire News

Here’s How Obesity Impacts RA Treatment Efficacy    DocWire News

Here’s How Obesity Impacts RA Treatment Efficacy - DocWire News

Here’s How Obesity Impacts RA Treatment Efficacy    DocWire News

RA Patients Still Have a "Considerable Need" for Treat-to-Target Care - Rheumatology Network

RA Patients Still Have a "Considerable Need" for Treat-to-Target Care    Rheumatology Network

What Blood Tests You Should Ask For Based On Your Family History - mindbodygreen.com

What Blood Tests You Should Ask For Based On Your Family History    mindbodygreen.com

EU marketing authorisation granted for rheumatoid arthritis treatment - European Pharmaceutical Review

EU marketing authorisation granted for rheumatoid arthritis treatment    European Pharmaceutical Review

EU marketing authorisation granted for rheumatoid arthritis treatment - European Pharmaceutical Review

EU marketing authorisation granted for rheumatoid arthritis treatment    European Pharmaceutical Review

Rheumatoid Arthritis Medications Frequently Discontinued by Pregnant Women - Rheumatology Advisor

Rheumatoid Arthritis Medications Frequently Discontinued by Pregnant Women    Rheumatology Advisor

Rheumatoid Arthritis Medications Frequently Discontinued by Pregnant Women - Rheumatology Advisor

Rheumatoid Arthritis Medications Frequently Discontinued by Pregnant Women    Rheumatology Advisor

Here’s How Obesity Impacts RA Treatment Efficacy - DocWire News

Here’s How Obesity Impacts RA Treatment Efficacy    DocWire News

Dear Annie: I’m worried an older co-worker is driving a wedge between a younger married couple - cleveland.com

Dear Annie: I’m worried an older co-worker is driving a wedge between a younger married couple    cleveland.com

Response Seen With Certolizumab Pegol After csDMARD Discontinuation in RA - Rheumatology Advisor

Response Seen With Certolizumab Pegol After csDMARD Discontinuation in RA    Rheumatology Advisor

European Commission approves subcutaneous infliximab biosimilar for RA - Healio

European Commission approves subcutaneous infliximab biosimilar for RA    Healio

Here’s How Obesity Impacts RA Treatment Efficacy - DocWire News

Here’s How Obesity Impacts RA Treatment Efficacy    DocWire News

Marin HIV survivor shares odds-beating lifestyle - Marin Independent Journal

Marin HIV survivor shares odds-beating lifestyle    Marin Independent Journal

Sustained Remission in RA Fails with Programmed Infliximab Treatment - Rheumatology Network

Sustained Remission in RA Fails with Programmed Infliximab Treatment    Rheumatology Network

Here’s How Obesity Impacts RA Treatment Efficacy - DocWire News

Here’s How Obesity Impacts RA Treatment Efficacy    DocWire News

ICER gets on board with AbbVie's Rinvoq for RA but frets over 'fair pricing' of next-gen drugs - FiercePharma

ICER gets on board with AbbVie's Rinvoq for RA but frets over 'fair pricing' of next-gen drugs    FiercePharma

ICER gets on board with AbbVie's Rinvoq for RA but frets over 'fair pricing' of next-gen drugs - FiercePharma

ICER gets on board with AbbVie's Rinvoq for RA but frets over 'fair pricing' of next-gen drugs    FiercePharma

Mobile Health Apps for Self-Management of Rheumatic and Musculoskeletal Diseases: Systematic Literature Review - DocWire News

Mobile Health Apps for Self-Management of Rheumatic and Musculoskeletal Diseases: Systematic Literature Review    DocWire News

Clock ticking on drug reform this year - Politico

Clock ticking on drug reform this year    Politico

Sustained Remission in RA Fails with Programmed Infliximab Treatment - Rheumatology Network

Sustained Remission in RA Fails with Programmed Infliximab Treatment    Rheumatology Network

Total Joint Replacement Improves Pain, Functional Quality of Life, and Health Utilities in Patients with Late-stage Knee and Hip Osteoarthritis for up to 5 Years - DocWire News

Total Joint Replacement Improves Pain, Functional Quality of Life, and Health Utilities in Patients with Late-stage Knee and Hip Osteoarthritis for up to 5 Years    DocWire News

Local woman creates pain management cream to prevent opioid abuse - CBS46 News Atlanta

Local woman creates pain management cream to prevent opioid abuse    CBS46 News Atlanta

Adjunctive Lovastatin Falls Short in Mildly Active Rheumatoid Arthritis - Rheumatology Advisor

Adjunctive Lovastatin Falls Short in Mildly Active Rheumatoid Arthritis    Rheumatology Advisor

Mobile Health Apps for Self-Management of Rheumatic and Musculoskeletal Diseases: Systematic Literature Review - DocWire News

Mobile Health Apps for Self-Management of Rheumatic and Musculoskeletal Diseases: Systematic Literature Review    DocWire News

Clock ticking on drug reform this year - Politico

Clock ticking on drug reform this year    Politico

RA Patients Still Have a "Considerable Need" for Treat-to-Target Care - Rheumatology Network

RA Patients Still Have a "Considerable Need" for Treat-to-Target Care    Rheumatology Network

RA Patients Still Have a "Considerable Need" for Treat-to-Target Care - Rheumatology Network

RA Patients Still Have a "Considerable Need" for Treat-to-Target Care    Rheumatology Network

Response Seen With Certolizumab Pegol After csDMARD Discontinuation in RA - Rheumatology Advisor

Response Seen With Certolizumab Pegol After csDMARD Discontinuation in RA    Rheumatology Advisor

Global Bone Densitometer Market Forecast, 2019-2024 - Lucrative Growth Opportunities in Emerging Markets - ResearchAndMarkets.com - Business Wire

Global Bone Densitometer Market Forecast, 2019-2024 - Lucrative Growth Opportunities in Emerging Markets - ResearchAndMarkets.com    Business Wire

Adjunctive Lovastatin Falls Short in Mildly Active Rheumatoid Arthritis - Rheumatology Advisor

Adjunctive Lovastatin Falls Short in Mildly Active Rheumatoid Arthritis    Rheumatology Advisor

Effectiveness of rituximab and abatacept not diminished in obese patients with RA - medwireNews

Effectiveness of rituximab and abatacept not diminished in obese patients with RA    medwireNews

Rheumatoid Arthritis Medications Frequently Discontinued by Pregnant Women - Rheumatology Advisor

Rheumatoid Arthritis Medications Frequently Discontinued by Pregnant Women    Rheumatology Advisor

Sustained Remission in RA Fails with Programmed Infliximab Treatment - Rheumatology Network

Sustained Remission in RA Fails with Programmed Infliximab Treatment    Rheumatology Network

Global Bone Densitometer Market Forecast, 2019-2024 - Lucrative Growth Opportunities in Emerging Markets - ResearchAndMarkets.com - Business Wire

Global Bone Densitometer Market Forecast, 2019-2024 - Lucrative Growth Opportunities in Emerging Markets - ResearchAndMarkets.com    Business Wire

RA remission with abatacept, methotrexate best maintained by continued treatment - Healio

RA remission with abatacept, methotrexate best maintained by continued treatment    Healio

Response Seen With Certolizumab Pegol After csDMARD Discontinuation in RA - Rheumatology Advisor

Response Seen With Certolizumab Pegol After csDMARD Discontinuation in RA    Rheumatology Advisor

European Commission approves subcutaneous infliximab biosimilar for RA - Healio

European Commission approves subcutaneous infliximab biosimilar for RA    Healio

Here’s How Obesity Impacts RA Treatment Efficacy - DocWire News

Here’s How Obesity Impacts RA Treatment Efficacy    DocWire News

10 foods to stay clear of if you have joint pain - Free Malaysia Today

10 foods to stay clear of if you have joint pain    Free Malaysia Today

Local woman creates pain management cream to prevent opioid abuse - CBS46 News Atlanta

Local woman creates pain management cream to prevent opioid abuse    CBS46 News Atlanta

For Rheumatoid Arthritis Patients, Anti-Inflammation Diet Improves Inflammatory Makers, Symptoms - Everyday Health

For Rheumatoid Arthritis Patients, Anti-Inflammation Diet Improves Inflammatory Makers, Symptoms    Everyday Health

Rheumatoid Arthritis Medications Frequently Discontinued by Pregnant Women - Rheumatology Advisor

Rheumatoid Arthritis Medications Frequently Discontinued by Pregnant Women    Rheumatology Advisor

Senior Rheumatoid Arthritis Patients May Be Missing Out on Treatments - Rheumatology Network

Senior Rheumatoid Arthritis Patients May Be Missing Out on Treatments    Rheumatology Network

Ultra-Low Rituximab Dose in RA Fails to Meet Non-Inferiority - Rheumatology Network

Ultra-Low Rituximab Dose in RA Fails to Meet Non-Inferiority    Rheumatology Network

No more aches and pains: 10 natural remedies for relieving painful arthritis - Starts at 60

No more aches and pains: 10 natural remedies for relieving painful arthritis    Starts at 60

Global Bone Densitometer Market Forecast, 2019-2024 - Lucrative Growth Opportunities in Emerging Markets - ResearchAndMarkets.com - Business Wire

Global Bone Densitometer Market Forecast, 2019-2024 - Lucrative Growth Opportunities in Emerging Markets - ResearchAndMarkets.com    Business Wire

Detecting rheumatoid arthritis gets easy, thanks to new thermal cameras - Economic Times

Detecting rheumatoid arthritis gets easy, thanks to new thermal cameras    Economic Times

Rheumatoid arthritis can now be detected through thermal cameras - Deccan Chronicle

Rheumatoid arthritis can now be detected through thermal cameras    Deccan Chronicle

Rheumatoid Arthritis Drugs Market 2019 - Industry Growth, Competitive Analysis, Future Prospects And Forecast 2025 - Montana Ledger

Rheumatoid Arthritis Drugs Market 2019 - Industry Growth, Competitive Analysis, Future Prospects And Forecast 2025    Montana Ledger

Global Rheumatoid Arthritis Drugs Market Data Analysis 2019-2025 : AbbVie, Boehringer Ingelheim, Novartis, Regeneron, Pfizer - News Agree

Global Rheumatoid Arthritis Drugs Market Data Analysis 2019-2025 : AbbVie, Boehringer Ingelheim, Novartis, Regeneron, Pfizer    News Agree

Study talks about the importance of early diagnosis in Rheumatoid Arthritis - Alpha News Report

Study talks about the importance of early diagnosis in Rheumatoid Arthritis    Alpha News Report

Thermal imaging a potential diagnosis tool to assess Rheumatoid Arthritis - Specialty Medical Dialogues

Thermal imaging a potential diagnosis tool to assess Rheumatoid Arthritis    Specialty Medical Dialogues

arthritis statistics - LoudCloudHealth

arthritis statistics    LoudCloudHealth

Global Rheumatoid Arthritis Drugs Market 2019 – AbbVie, Amgen, Bayer, Biogen, Boehringer Ingelheim - Eastlake Times

Global Rheumatoid Arthritis Drugs Market 2019 – AbbVie, Amgen, Bayer, Biogen, Boehringer Ingelheim    Eastlake Times

RISK RA: Certain ACPA antibodies, tenosynovitis predicted RA onset - Healio

RISK RA: Certain ACPA antibodies, tenosynovitis predicted RA onset    Healio

Global Rheumatoid Arthritis Drugs Market Data Analysis 2019-2025 : AbbVie, Boehringer Ingelheim, Novartis, Regeneron, Pfizer - News Agree

Global Rheumatoid Arthritis Drugs Market Data Analysis 2019-2025 : AbbVie, Boehringer Ingelheim, Novartis, Regeneron, Pfizer    News Agree

ICER gets on board with AbbVie's Rinvoq for RA but frets over 'fair pricing' of next-gen drugs - FiercePharma

ICER gets on board with AbbVie's Rinvoq for RA but frets over 'fair pricing' of next-gen drugs    FiercePharma

RISK RA: Certain ACPA antibodies, tenosynovitis predicted RA onset - Healio

RISK RA: Certain ACPA antibodies, tenosynovitis predicted RA onset    Healio

Heat scanners could detect rheumatoid arthritis 'because patients' palms are hotter than normal' - Headlinez Pro

Heat scanners could detect rheumatoid arthritis 'because patients' palms are hotter than normal'    Headlinez Pro

Detecting rheumatoid arthritis gets easy, thanks to new thermal cameras - Economic Times

Detecting rheumatoid arthritis gets easy, thanks to new thermal cameras    Economic Times

Rheumatoid arthritis can now be detected through thermal cameras - Deccan Chronicle

Rheumatoid arthritis can now be detected through thermal cameras    Deccan Chronicle

European Commission approves subcutaneous infliximab biosimilar for RA - Healio

European Commission approves subcutaneous infliximab biosimilar for RA    Healio

Electroceuticals World Market Study, 2019: Coverage of Epilepsy, Cardiovascular Diseases, Rheumatoid Arthritis & Diabetes Treatment Using Electroceuticals - P&T Community

Electroceuticals World Market Study, 2019: Coverage of Epilepsy, Cardiovascular Diseases, Rheumatoid Arthritis & Diabetes Treatment Using Electroceuticals    P&T Community

Biologic DMARDs similarly safe, effective in elderly- and young-onset RA - Healio

Biologic DMARDs similarly safe, effective in elderly- and young-onset RA    Healio

UK's Labor accuses government of secret trade talks with US - NBC Montana

UK's Labor accuses government of secret trade talks with US    NBC Montana

arthritis statistics - LoudCloudHealth

arthritis statistics    LoudCloudHealth

Global Seropositive Rheumatoid Arthritis Drug Market 2015-2026 | Abbott Laboratories (U.S.), Johnson & Johnson Limited (U.S.), Novartis AG (Switzerland), Pfizer, Inc. (U.S.) - Health 365 News

Global Seropositive Rheumatoid Arthritis Drug Market 2015-2026 | Abbott Laboratories (U.S.), Johnson & Johnson Limited (U.S.), Novartis AG (Switzerland), Pfizer, Inc. (U.S.)    Health 365 News

Electroceuticals World Market Study, 2019: Coverage of Epilepsy, Cardiovascular Diseases, Rheumatoid Arthritis & Diabetes Treatment Using Electroceuticals - PRNewswire

Electroceuticals World Market Study, 2019: Coverage of Epilepsy, Cardiovascular Diseases, Rheumatoid Arthritis & Diabetes Treatment Using Electroceuticals    PRNewswire

CRUP Tool Makes Enhancer Prediction Quick and Easy - Technology Networks

CRUP Tool Makes Enhancer Prediction Quick and Easy    Technology Networks

Swiss army knife for genome research - EurekAlert

Swiss army knife for genome research    EurekAlert

Electroceuticals World Market Study, 2019: Coverage of Epilepsy, Cardiovascular Diseases, Rheumatoid Arthritis & Diabetes Treatment Using Electroceuticals - P&T Community

Electroceuticals World Market Study, 2019: Coverage of Epilepsy, Cardiovascular Diseases, Rheumatoid Arthritis & Diabetes Treatment Using Electroceuticals    P&T Community

UK's Labor accuses government of secret trade talks with US - NBC Montana

UK's Labor accuses government of secret trade talks with US    NBC Montana

Biologic DMARDs similarly safe, effective in elderly- and young-onset RA - Healio

Biologic DMARDs similarly safe, effective in elderly- and young-onset RA    Healio

Electroceuticals World Market Study, 2019: Coverage of Epilepsy, Cardiovascular Diseases, Rheumatoid Arthritis & Diabetes Treatment Using Electroceuticals - PRNewswire

Electroceuticals World Market Study, 2019: Coverage of Epilepsy, Cardiovascular Diseases, Rheumatoid Arthritis & Diabetes Treatment Using Electroceuticals    PRNewswire

10 years of life-changing FDA approvals - MD Linx

10 years of life-changing FDA approvals    MD Linx

arthritis statistics - LoudCloudHealth

arthritis statistics    LoudCloudHealth

Biologic DMARDs similarly safe, effective in elderly- and young-onset RA - Healio

Biologic DMARDs similarly safe, effective in elderly- and young-onset RA    Healio

Here’s How Obesity Impacts RA Treatment Efficacy - DocWire News

Here’s How Obesity Impacts RA Treatment Efficacy    DocWire News

10 years of life-changing FDA approvals - MD Linx

10 years of life-changing FDA approvals    MD Linx

arthritis statistics - LoudCloudHealth

arthritis statistics    LoudCloudHealth

Opioid-Induced Constipation: Pathophysiology & Disease Burden - MD Magazine

Opioid-Induced Constipation: Pathophysiology & Disease Burden    MD Magazine

arthritis statistics - LoudCloudHealth

arthritis statistics    LoudCloudHealth

Opioid-Induced Constipation: Pathophysiology & Disease Burden - Pharmacy Times

Opioid-Induced Constipation: Pathophysiology & Disease Burden    Pharmacy Times

10 years of life-changing FDA approvals - MD Linx

10 years of life-changing FDA approvals    MD Linx

arthritis statistics - LoudCloudHealth

arthritis statistics    LoudCloudHealth

New chromatography resin enters commercial production - The Science Board

New chromatography resin enters commercial production    The Science Board

Electroceuticals World Market Study, 2019: Coverage of Epilepsy, Cardiovascular Diseases, Rheumatoid Arthritis & Diabetes Treatment Using Electroceuticals - P&T Community

Electroceuticals World Market Study, 2019: Coverage of Epilepsy, Cardiovascular Diseases, Rheumatoid Arthritis & Diabetes Treatment Using Electroceuticals    P&T Community

Myriad Genetics' Test Added in Disease Activity Measure List - Yahoo Finance

Myriad Genetics' Test Added in Disease Activity Measure List    Yahoo Finance

Latest Research Report to uncover key Factors of Global Drugs for Rheumatoid Arthritis Market - Internet Shots

Latest Research Report to uncover key Factors of Global Drugs for Rheumatoid Arthritis Market    Internet Shots

Electroceuticals World Market Study, 2019: Coverage of Epilepsy, Cardiovascular Diseases, Rheumatoid Arthritis & Diabetes Treatment Using Electroceuticals - PRNewswire

Electroceuticals World Market Study, 2019: Coverage of Epilepsy, Cardiovascular Diseases, Rheumatoid Arthritis & Diabetes Treatment Using Electroceuticals    PRNewswire

Despite flare prevalence with checkpoint inhibitors, patients with RA rarely discontinue - Healio

Despite flare prevalence with checkpoint inhibitors, patients with RA rarely discontinue    Healio

Tocilizumab More Effective than Rituximab in Certain Patients with RA - Pharmacy Times

Tocilizumab More Effective than Rituximab in Certain Patients with RA    Pharmacy Times

Latest Research Report to uncover key Factors of Global Drugs for Rheumatoid Arthritis Market - Internet Shots

Latest Research Report to uncover key Factors of Global Drugs for Rheumatoid Arthritis Market    Internet Shots

Opioid-Induced Constipation: Pathophysiology & Disease Burden - Pharmacy Times

Opioid-Induced Constipation: Pathophysiology & Disease Burden    Pharmacy Times

Thermal cameras effective in detecting rheumatoid arthritis - EurekAlert

Thermal cameras effective in detecting rheumatoid arthritis    EurekAlert

Electroceuticals World Market Study, 2019: Coverage of Epilepsy, Cardiovascular Diseases, Rheumatoid Arthritis & Diabetes Treatment Using Electroceuticals - P&T Community

Electroceuticals World Market Study, 2019: Coverage of Epilepsy, Cardiovascular Diseases, Rheumatoid Arthritis & Diabetes Treatment Using Electroceuticals    P&T Community

Comorbidities as risk factors for rheumatoid arthritis and their accrual after diagnosis - MD Linx

Comorbidities as risk factors for rheumatoid arthritis and their accrual after diagnosis    MD Linx

Opioid-Induced Constipation: Pathophysiology & Disease Burden - MD Magazine

Opioid-Induced Constipation: Pathophysiology & Disease Burden    MD Magazine

Myriad Genetics' Test Added in Disease Activity Measure List - Yahoo Finance

Myriad Genetics' Test Added in Disease Activity Measure List    Yahoo Finance

10 years of life-changing FDA approvals - MD Linx

10 years of life-changing FDA approvals    MD Linx

Araim Pharmaceuticals Selects Ferry Breedveld as Acting CEO - P&T Community

Araim Pharmaceuticals Selects Ferry Breedveld as Acting CEO    P&T Community

New chromatography resin enters commercial production - The Science Board

New chromatography resin enters commercial production    The Science Board

Electroceuticals World Market Study, 2019: Coverage of Epilepsy, Cardiovascular Diseases, Rheumatoid Arthritis & Diabetes Treatment Using Electroceuticals - PRNewswire

Electroceuticals World Market Study, 2019: Coverage of Epilepsy, Cardiovascular Diseases, Rheumatoid Arthritis & Diabetes Treatment Using Electroceuticals    PRNewswire

Researchers Working to Understand Why Some Patients with Autoimmune Diseases Develop Diabetes Instead of Arthritis - BioSpace

Researchers Working to Understand Why Some Patients with Autoimmune Diseases Develop Diabetes Instead of Arthritis    BioSpace

Upadacitinib for Rheumatic Condition Ankylosing Spondylitis - MedicalResearch.com

Upadacitinib for Rheumatic Condition Ankylosing Spondylitis    MedicalResearch.com

OFCCP Week In Review: November 2019 #4 | DirectEmployers Association - JD Supra

OFCCP Week In Review: November 2019 #4 | DirectEmployers Association    JD Supra

Rheumatoid Arthritis Treatment Market Report (2018-2026) | The demand for the Market will drastically increase in the Future… | Download Sample Copy - Crypto Journal

Rheumatoid Arthritis Treatment Market Report (2018-2026) | The demand for the Market will drastically increase in the Future… | Download Sample Copy    Crypto Journal

Opioid-Induced Constipation: Pathophysiology & Disease Burden - Pharmacy Times

Opioid-Induced Constipation: Pathophysiology & Disease Burden    Pharmacy Times

Biologic DMARDs similarly safe, effective in elderly- and young-onset RA - Healio

Biologic DMARDs similarly safe, effective in elderly- and young-onset RA    Healio

Synovitis Detection by Grey Scale Ultrasound Predicts Erosions in Rheumatoid Arthritis - Rheumatology Advisor

Synovitis Detection by Grey Scale Ultrasound Predicts Erosions in Rheumatoid Arthritis    Rheumatology Advisor

Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial - The Lancet

Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial    The Lancet

RA Treatment: Influence of Sex, Drugs, and Obesity - MedPage Today

RA Treatment: Influence of Sex, Drugs, and Obesity    MedPage Today

High Rate of Discordance Between Clinical and Ultrasound Assessment in RA - Rheumatology Advisor

High Rate of Discordance Between Clinical and Ultrasound Assessment in RA    Rheumatology Advisor

Start Treatment Early in RA, Even in Seronegatives - MedPage Today

Start Treatment Early in RA, Even in Seronegatives    MedPage Today

Researchers Working to Understand Why Some Patients with Autoimmune Diseases Develop Diabetes Instead of Arthritis - BioSpace

Researchers Working to Understand Why Some Patients with Autoimmune Diseases Develop Diabetes Instead of Arthritis    BioSpace

Rheumatoid Arthritis Drugs/ Therapeutics Market 2019 Size, Share, Application, Industry Demand, Regional Growth and Sales Channels - Montana Ledger

Rheumatoid Arthritis Drugs/ Therapeutics Market 2019 Size, Share, Application, Industry Demand, Regional Growth and Sales Channels    Montana Ledger

Support Market 2019 Global Trend, Segmentation and Opportunities Forecast To 2028 - MENAFN.COM

Support Market 2019 Global Trend, Segmentation and Opportunities Forecast To 2028    MENAFN.COM

Rheumatoid Arthritis (RA) Drugs Market Innovative Strategy by 2025 | AbbVie, Roche, Johnson & Johnson - VaporBlash

Rheumatoid Arthritis (RA) Drugs Market Innovative Strategy by 2025 | AbbVie, Roche, Johnson & Johnson    VaporBlash

Global Ulcerative Colitis Immunology Drugs Market Growth 2019-2025 – Janssen Biotech, Inc., Bristol-Myers Squibb Company, AbbVie Inc. - Daily Industry News Journal

Global Ulcerative Colitis Immunology Drugs Market Growth 2019-2025 – Janssen Biotech, Inc., Bristol-Myers Squibb Company, AbbVie Inc.    Daily Industry News Journal

Global Tyrosine Kinase JAK Inhibitors Market Insights 2019 : Pfizer, Incyte, Novartis, Eli Lilly, Gilead, Sanofi, Galapagos, AbbVie - Global News Reports 24

Global Tyrosine Kinase JAK Inhibitors Market Insights 2019 : Pfizer, Incyte, Novartis, Eli Lilly, Gilead, Sanofi, Galapagos, AbbVie    Global News Reports 24

Global PEGylated Proteins Market Insights Report 2019-2025: Merck Sharp & Dohme, ENZON Pharmaceuticals, Roche, Pfizer, Amgen, UCB - Global News Reports 24

Global PEGylated Proteins Market Insights Report 2019-2025: Merck Sharp & Dohme, ENZON Pharmaceuticals, Roche, Pfizer, Amgen, UCB    Global News Reports 24

Global Total Ankle Replacement Market Growth Analysis, Forecasts to 2025 : Integra LifeSciences Corporation, Wright Medical Technology, Inc - PR Industry News

Global Total Ankle Replacement Market Growth Analysis, Forecasts to 2025 : Integra LifeSciences Corporation, Wright Medical Technology, Inc    PR Industry News

IBD, Diabetes Can Raise Your Risk for Rheumatoid Arthritis - Healthline

IBD, Diabetes Can Raise Your Risk for Rheumatoid Arthritis    Healthline

Biologic DMARDs similarly safe, effective in elderly- and young-onset RA - Healio

Biologic DMARDs similarly safe, effective in elderly- and young-onset RA    Healio

Synovitis Detection by Grey Scale Ultrasound Predicts Erosions in Rheumatoid Arthritis - Rheumatology Advisor

Synovitis Detection by Grey Scale Ultrasound Predicts Erosions in Rheumatoid Arthritis    Rheumatology Advisor

Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial - The Lancet

Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial    The Lancet

RA Treatment: Influence of Sex, Drugs, and Obesity - MedPage Today

RA Treatment: Influence of Sex, Drugs, and Obesity    MedPage Today

High Rate of Discordance Between Clinical and Ultrasound Assessment in RA - Rheumatology Advisor

High Rate of Discordance Between Clinical and Ultrasound Assessment in RA    Rheumatology Advisor

Start Treatment Early in RA, Even in Seronegatives - MedPage Today

Start Treatment Early in RA, Even in Seronegatives    MedPage Today

Researchers Working to Understand Why Some Patients with Autoimmune Diseases Develop Diabetes Instead of Arthritis - BioSpace

Researchers Working to Understand Why Some Patients with Autoimmune Diseases Develop Diabetes Instead of Arthritis    BioSpace

Support Market 2019 Global Trend, Segmentation and Opportunities Forecast To 2028 - MENAFN.COM

Support Market 2019 Global Trend, Segmentation and Opportunities Forecast To 2028    MENAFN.COM

Blood-derived serum tears go beyond conventional therapy - Optometry Times

Blood-derived serum tears go beyond conventional therapy    Optometry Times

Despite flare prevalence with checkpoint inhibitors, patients with RA rarely discontinue - Healio

Despite flare prevalence with checkpoint inhibitors, patients with RA rarely discontinue    Healio

Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial - The Lancet

Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial    The Lancet

Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial - The Lancet

Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial    The Lancet

RISK RA: Certain ACPA antibodies, tenosynovitis predicted RA onset - Healio

RISK RA: Certain ACPA antibodies, tenosynovitis predicted RA onset    Healio

Arthritis Risk Underestimated in Children With Down Syndrome - Medscape

Arthritis Risk Underestimated in Children With Down Syndrome    Medscape

Intervention bundle improves flu vaccination rates in RA/JIA patients - Healio

Intervention bundle improves flu vaccination rates in RA/JIA patients    Healio

Pfizer Wins FDA Approval for Biosimilar of AbbVie's Humira - BioSpace

Pfizer Wins FDA Approval for Biosimilar of AbbVie's Humira    BioSpace

Purolite's Praesto® Agarose-based Chromatography Resins Move Into the Commercial Manufacturing of FDA-Approved Biotherapeutics - BioSpace

Purolite's Praesto® Agarose-based Chromatography Resins Move Into the Commercial Manufacturing of FDA-Approved Biotherapeutics    BioSpace

Blood-derived serum tears go beyond conventional therapy - Optometry Times

Blood-derived serum tears go beyond conventional therapy    Optometry Times

Despite flare prevalence with checkpoint inhibitors, patients with RA rarely discontinue - Healio

Despite flare prevalence with checkpoint inhibitors, patients with RA rarely discontinue    Healio

Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial - The Lancet

Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial    The Lancet

RISK RA: Certain ACPA antibodies, tenosynovitis predicted RA onset - Healio

RISK RA: Certain ACPA antibodies, tenosynovitis predicted RA onset    Healio

Arthritis Risk Underestimated in Children With Down Syndrome - Medscape

Arthritis Risk Underestimated in Children With Down Syndrome    Medscape

Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial - The Lancet

Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial    The Lancet

Despite flare prevalence with checkpoint inhibitors, patients with RA rarely discontinue - Healio

Despite flare prevalence with checkpoint inhibitors, patients with RA rarely discontinue    Healio

Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial - The Lancet

Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial    The Lancet

Intervention bundle improves flu vaccination rates in RA/JIA patients - Healio

Intervention bundle improves flu vaccination rates in RA/JIA patients    Healio

Pfizer Wins FDA Approval for Biosimilar of AbbVie's Humira - BioSpace

Pfizer Wins FDA Approval for Biosimilar of AbbVie's Humira    BioSpace

Purolite's Praesto® Agarose-based Chromatography Resins Move Into the Commercial Manufacturing of FDA-Approved Biotherapeutics - BioSpace

Purolite's Praesto® Agarose-based Chromatography Resins Move Into the Commercial Manufacturing of FDA-Approved Biotherapeutics    BioSpace

RISK RA: Certain ACPA antibodies, tenosynovitis predicted RA onset - Healio

RISK RA: Certain ACPA antibodies, tenosynovitis predicted RA onset    Healio

Arthritis Risk Underestimated in Children With Down Syndrome - Medscape

Arthritis Risk Underestimated in Children With Down Syndrome    Medscape

Warren Buffett's 3 Best Performing Stocks So Far This Year: Are They Buys Now? - Nasdaq

Warren Buffett's 3 Best Performing Stocks So Far This Year: Are They Buys Now?    Nasdaq

Rio Rancho teen overcomes rheumatoid arthritis through sports - KOAT New Mexico

Rio Rancho teen overcomes rheumatoid arthritis through sports    KOAT New Mexico

Glucocorticoid Prescribing Practices Vary Widely in Incident RA - Rheumatology Advisor

Glucocorticoid Prescribing Practices Vary Widely in Incident RA    Rheumatology Advisor

How Pharmacists Can Help Rheumatoid Arthritis Patients - Drug Topics

How Pharmacists Can Help Rheumatoid Arthritis Patients    Drug Topics

Upadacitinib improves signs, symptoms in patients with active AS - Healio

Upadacitinib improves signs, symptoms in patients with active AS    Healio

Start Treatment Early in RA, Even in Seronegatives - MedPage Today

Start Treatment Early in RA, Even in Seronegatives    MedPage Today

Pharmaceutical innovation can help Canadians in pain, and the economy - The Hill Times

Pharmaceutical innovation can help Canadians in pain, and the economy    The Hill Times

Poor health literacy, wait times drive influenza vaccine hesitancy in RA, JIA - Healio

Poor health literacy, wait times drive influenza vaccine hesitancy in RA, JIA    Healio

Rio Rancho teen overcomes rheumatoid arthritis through sports - KOAT New Mexico

Rio Rancho teen overcomes rheumatoid arthritis through sports    KOAT New Mexico

Can Antibiotics Increase the Risk of Arthritis? - News-Medical.net

Can Antibiotics Increase the Risk of Arthritis?    News-Medical.net

Pharmaceutical innovation can help Canadians in pain, and the economy - The Hill Times

Pharmaceutical innovation can help Canadians in pain, and the economy    The Hill Times

Regeneron Pharmaceuticals Inc. (REGN) Rises 2.82% for November 22 - Equities.com

Regeneron Pharmaceuticals Inc. (REGN) Rises 2.82% for November 22    Equities.com

Start Treatment Early in RA, Even in Seronegatives - MedPage Today

Start Treatment Early in RA, Even in Seronegatives    MedPage Today

Despite flare prevalence with checkpoint inhibitors, patients with RA rarely discontinue - Healio

Despite flare prevalence with checkpoint inhibitors, patients with RA rarely discontinue    Healio

Electroceuticals World Market Study, 2019: Coverage of Epilepsy, Cardiovascular Diseases, Rheumatoid Arthritis & Diabetes Treatment Using Electroceuticals - PRNewswire

Electroceuticals World Market Study, 2019: Coverage of Epilepsy, Cardiovascular Diseases, Rheumatoid Arthritis & Diabetes Treatment Using Electroceuticals    PRNewswire

What Type of Doctor Treats Arthritis? - Health Essentials from Cleveland Clinic

What Type of Doctor Treats Arthritis?    Health Essentials from Cleveland Clinic

PsA diagnosis often delayed in dermatology vs. rheumatology - Healio

PsA diagnosis often delayed in dermatology vs. rheumatology    Healio

Despite flare prevalence with checkpoint inhibitors, patients with RA rarely discontinue - Healio

Despite flare prevalence with checkpoint inhibitors, patients with RA rarely discontinue    Healio

Rio Rancho teen overcomes rheumatoid arthritis through sports - KOAT New Mexico

Rio Rancho teen overcomes rheumatoid arthritis through sports    KOAT New Mexico

Glucocorticoid Prescribing Practices Vary Widely in Incident RA - Rheumatology Advisor

Glucocorticoid Prescribing Practices Vary Widely in Incident RA    Rheumatology Advisor

How Pharmacists Can Help Rheumatoid Arthritis Patients - Drug Topics

How Pharmacists Can Help Rheumatoid Arthritis Patients    Drug Topics

Upadacitinib improves signs, symptoms in patients with active AS - Healio

Upadacitinib improves signs, symptoms in patients with active AS    Healio

Start Treatment Early in RA, Even in Seronegatives - MedPage Today

Start Treatment Early in RA, Even in Seronegatives    MedPage Today

Electroceuticals World Market Study, 2019: Coverage of Epilepsy, Cardiovascular Diseases, Rheumatoid Arthritis & Diabetes Treatment Using Electroceuticals - P&T Community

Electroceuticals World Market Study, 2019: Coverage of Epilepsy, Cardiovascular Diseases, Rheumatoid Arthritis & Diabetes Treatment Using Electroceuticals    P&T Community

Q&A: What can I do to limit joint pain from arthritis? - The Philadelphia Inquirer

Q&A: What can I do to limit joint pain from arthritis?    The Philadelphia Inquirer

Poor health literacy, wait times drive influenza vaccine hesitancy in RA, JIA - Healio

Poor health literacy, wait times drive influenza vaccine hesitancy in RA, JIA    Healio

The American College of Rheumatology Adds the Vectra® Test to List of Recommended Disease Activity Measures for Rheumatoid Arthritis - BioSpace

The American College of Rheumatology Adds the Vectra® Test to List of Recommended Disease Activity Measures for Rheumatoid Arthritis    BioSpace

Araim Pharmaceuticals Selects Ferry Breedveld as Acting CEO - BioSpace

Araim Pharmaceuticals Selects Ferry Breedveld as Acting CEO    BioSpace

Pfizer Wins FDA Approval for Biosimilar of AbbVie's Humira - BioSpace

Pfizer Wins FDA Approval for Biosimilar of AbbVie's Humira    BioSpace

Opioid-Induced Constipation: Pathophysiology & Disease Burden - Pharmacy Times

Opioid-Induced Constipation: Pathophysiology & Disease Burden    Pharmacy Times

FDA approves Abrilada, fifth Humira biosimilar - Healio

FDA approves Abrilada, fifth Humira biosimilar    Healio

Maternal use of non-TNF inhibitor biologic, tofacitinib pose minimal infectious risk to offspring - Healio

Maternal use of non-TNF inhibitor biologic, tofacitinib pose minimal infectious risk to offspring    Healio

Live Varicella Vaccine Is Safe and Effective in Patients Taking TNF Inhibitors - Rheumatology Network

Live Varicella Vaccine Is Safe and Effective in Patients Taking TNF Inhibitors    Rheumatology Network

Maternal use of non-TNF inhibitor biologic, tofacitinib pose minimal infectious risk to offspring - Healio

Maternal use of non-TNF inhibitor biologic, tofacitinib pose minimal infectious risk to offspring    Healio

Q&A: What can I do to limit joint pain from arthritis? - The Philadelphia Inquirer

Q&A: What can I do to limit joint pain from arthritis?    The Philadelphia Inquirer

Poor health literacy, wait times drive influenza vaccine hesitancy in RA, JIA - Healio

Poor health literacy, wait times drive influenza vaccine hesitancy in RA, JIA    Healio

The American College of Rheumatology Adds the Vectra® Test to List of Recommended Disease Activity Measures for Rheumatoid Arthritis - BioSpace

The American College of Rheumatology Adds the Vectra® Test to List of Recommended Disease Activity Measures for Rheumatoid Arthritis    BioSpace

How Pharmacists Can Help Rheumatoid Arthritis Patients - Drug Topics

How Pharmacists Can Help Rheumatoid Arthritis Patients    Drug Topics

Slightly Increased Serious Infection Risk With Biologic vs Synthetic DMARDs in RA - Rheumatology Advisor

Slightly Increased Serious Infection Risk With Biologic vs Synthetic DMARDs in RA    Rheumatology Advisor

Pfizer’s Xeljanz In the Crowded Rheumatoid Drugs Market - Forbes

Pfizer’s Xeljanz In the Crowded Rheumatoid Drugs Market    Forbes

FDA approves Abrilada, fifth Humira biosimilar - Healio

FDA approves Abrilada, fifth Humira biosimilar    Healio

How Pharmacists Can Help Rheumatoid Arthritis Patients - Drug Topics

How Pharmacists Can Help Rheumatoid Arthritis Patients    Drug Topics

How Pharmacists Can Help Rheumatoid Arthritis Patients - Drug Topics

How Pharmacists Can Help Rheumatoid Arthritis Patients    Drug Topics

Slightly Increased Serious Infection Risk With Biologic vs Synthetic DMARDs in RA - Rheumatology Advisor

Slightly Increased Serious Infection Risk With Biologic vs Synthetic DMARDs in RA    Rheumatology Advisor

Pfizer’s Xeljanz In the Crowded Rheumatoid Drugs Market - Forbes

Pfizer’s Xeljanz In the Crowded Rheumatoid Drugs Market    Forbes

Maternal use of non-TNF inhibitor biologic, tofacitinib pose minimal infectious risk to offspring - Healio

Maternal use of non-TNF inhibitor biologic, tofacitinib pose minimal infectious risk to offspring    Healio

How Pharmacists Can Help Rheumatoid Arthritis Patients - Drug Topics

How Pharmacists Can Help Rheumatoid Arthritis Patients    Drug Topics

High Rate of Discordance Between Clinical and Ultrasound Assessment in RA - Rheumatology Advisor

High Rate of Discordance Between Clinical and Ultrasound Assessment in RA    Rheumatology Advisor

High Rate of Discordance Between Clinical and Ultrasound Assessment in RA - Rheumatology Advisor

High Rate of Discordance Between Clinical and Ultrasound Assessment in RA    Rheumatology Advisor

People's Pharmacy: Corticosteroid injections in joints can have negative side effects - Winston-Salem Journal

People's Pharmacy: Corticosteroid injections in joints can have negative side effects    Winston-Salem Journal

Arthritis Risk Underestimated in Children With Down Syndrome - Medscape

Arthritis Risk Underestimated in Children With Down Syndrome    Medscape

Opioid-Induced Constipation: Pathophysiology & Disease Burden - MD Magazine

Opioid-Induced Constipation: Pathophysiology & Disease Burden    MD Magazine

Pain, fatigue topped list of symptoms most important to patients with rheumatic disease - Healio

Pain, fatigue topped list of symptoms most important to patients with rheumatic disease    Healio

Glucocorticoid Prescribing Practices Vary Widely in Incident RA - Rheumatology Advisor

Glucocorticoid Prescribing Practices Vary Widely in Incident RA    Rheumatology Advisor

How Pharmacists Can Help Rheumatoid Arthritis Patients - Drug Topics

How Pharmacists Can Help Rheumatoid Arthritis Patients    Drug Topics

Novel Vagus Nerve Stimulator Well-Tolerated in Drug Refractory Rheumatoid Arthritis - Neurology Advisor

Novel Vagus Nerve Stimulator Well-Tolerated in Drug Refractory Rheumatoid Arthritis    Neurology Advisor

Arthritis Risk Underestimated in Children With Down Syndrome - Medscape

Arthritis Risk Underestimated in Children With Down Syndrome    Medscape

New chromatography resin enters commercial production - The Science Board

New chromatography resin enters commercial production    The Science Board

A Lancaster mum with suspected Crohn's describes how the In My Shoes app created by Crohn’s and Colitis UK helps people understand what she has to go through on a daily basis - The Visitor

A Lancaster mum with suspected Crohn's describes how the In My Shoes app created by Crohn’s and Colitis UK helps people understand what she has to go through on a daily basis    The Visitor

How Pharmacists Can Help Rheumatoid Arthritis Patients - Drug Topics

How Pharmacists Can Help Rheumatoid Arthritis Patients    Drug Topics

Glucocorticoid Prescribing Practices Vary Widely in Incident RA - Rheumatology Advisor

Glucocorticoid Prescribing Practices Vary Widely in Incident RA    Rheumatology Advisor

How Pharmacists Can Help Rheumatoid Arthritis Patients - Drug Topics

How Pharmacists Can Help Rheumatoid Arthritis Patients    Drug Topics

Pfizer's Xeljanz gets EMA blood clots warning following FDA's similar move - FiercePharma

Pfizer's Xeljanz gets EMA blood clots warning following FDA's similar move    FiercePharma

FDA Approves Pfizer's Biosimilar, ABRILADA™ (adalimumab-afzb) for Multiple Inflammatory Conditions | Antibodies | News Channels - PipelineReview.com

FDA Approves Pfizer's Biosimilar, ABRILADA™ (adalimumab-afzb) for Multiple Inflammatory Conditions | Antibodies | News Channels    PipelineReview.com

Araim Pharmaceuticals Selects Ferry Breedveld as Acting CEO - BioSpace

Araim Pharmaceuticals Selects Ferry Breedveld as Acting CEO    BioSpace

Pfizer's Xeljanz gets EMA blood clots warning following FDA's similar move - FiercePharma

Pfizer's Xeljanz gets EMA blood clots warning following FDA's similar move    FiercePharma

Pain, fatigue topped list of symptoms most important to patients with rheumatic disease - Healio

Pain, fatigue topped list of symptoms most important to patients with rheumatic disease    Healio

Novel Vagus Nerve Stimulator Well-Tolerated in Drug Refractory Rheumatoid Arthritis - Neurology Advisor

Novel Vagus Nerve Stimulator Well-Tolerated in Drug Refractory Rheumatoid Arthritis    Neurology Advisor

Deep Dive: What you need to know before using CBD products - KING5.com

Deep Dive: What you need to know before using CBD products    KING5.com

Researchers split the 'AtoM' in search of a treatment for rheumatoid arthritis - Medical Xpress

Researchers split the 'AtoM' in search of a treatment for rheumatoid arthritis    Medical Xpress

Q&A: What can I do to limit joint pain from arthritis? - The Philadelphia Inquirer

Q&A: What can I do to limit joint pain from arthritis?    The Philadelphia Inquirer

Pfizer gets biosimilar approved for Humira, setting up competition — in 2023 - Endpoints News

Pfizer gets biosimilar approved for Humira, setting up competition — in 2023    Endpoints News

IBD, Diabetes Can Raise Your Risk for Rheumatoid Arthritis - Healthline

IBD, Diabetes Can Raise Your Risk for Rheumatoid Arthritis    Healthline

Q&A: What can I do to limit joint pain from arthritis? - The Philadelphia Inquirer

Q&A: What can I do to limit joint pain from arthritis?    The Philadelphia Inquirer

Sarilumab as a Combination or Monotherapy Successfully Targets IL-6, Improves Symptoms in Patients With RA - AJMC.com Managed Markets Network

Sarilumab as a Combination or Monotherapy Successfully Targets IL-6, Improves Symptoms in Patients With RA    AJMC.com Managed Markets Network

IBD, Diabetes Can Raise Your Risk for Rheumatoid Arthritis - Healthline

IBD, Diabetes Can Raise Your Risk for Rheumatoid Arthritis    Healthline

IBD, Diabetes Can Raise Your Risk for Rheumatoid Arthritis - Healthline

IBD, Diabetes Can Raise Your Risk for Rheumatoid Arthritis    Healthline

IBD, Diabetes Can Raise Your Risk for Rheumatoid Arthritis - Healthline

IBD, Diabetes Can Raise Your Risk for Rheumatoid Arthritis    Healthline

IBD, Diabetes Can Raise Your Risk for Rheumatoid Arthritis - Healthline

IBD, Diabetes Can Raise Your Risk for Rheumatoid Arthritis    Healthline

Comorbidities quickly accumulate after rheumatoid arthritis diagnosis - Clinical Daily News - McKnight's Long Term Care News

Comorbidities quickly accumulate after rheumatoid arthritis diagnosis - Clinical Daily News    McKnight's Long Term Care News

FDA approves Abrilada, fifth Humira biosimilar - Healio

FDA approves Abrilada, fifth Humira biosimilar    Healio

Q&A: What can I do to limit joint pain from arthritis? - The Philadelphia Inquirer

Q&A: What can I do to limit joint pain from arthritis?    The Philadelphia Inquirer

How to reverse hair loss from medication - Medical News Today

How to reverse hair loss from medication    Medical News Today

Arthritis Risk Underestimated in Children With Down Syndrome - Medscape

Arthritis Risk Underestimated in Children With Down Syndrome    Medscape

Q&A: What can I do to limit joint pain from arthritis? - The Philadelphia Inquirer

Q&A: What can I do to limit joint pain from arthritis?    The Philadelphia Inquirer

Sarilumab as a Combination or Monotherapy Successfully Targets IL-6, Improves Symptoms in Patients With RA - AJMC.com Managed Markets Network

Sarilumab as a Combination or Monotherapy Successfully Targets IL-6, Improves Symptoms in Patients With RA    AJMC.com Managed Markets Network

Researchers split the 'AtoM' in search of a treatment for rheumatoid arthritis - Medical Xpress

Researchers split the 'AtoM' in search of a treatment for rheumatoid arthritis    Medical Xpress

Q&A: What can I do to limit joint pain from arthritis? - The Philadelphia Inquirer

Q&A: What can I do to limit joint pain from arthritis?    The Philadelphia Inquirer

FDA Approves Pfizer's Biosimilar, ABRILADA™ (adalimumab-afzb) for Multiple Inflammatory Conditions | Antibodies | News Channels - PipelineReview.com

FDA Approves Pfizer's Biosimilar, ABRILADA™ (adalimumab-afzb) for Multiple Inflammatory Conditions | Antibodies | News Channels    PipelineReview.com

Global Rheumatoid Arthritis Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025 - Industry News Info

Global Rheumatoid Arthritis Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025    Industry News Info

Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial - The Lancet

Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial    The Lancet

MEDICAL BREAKTHROUGHS: Dangers of Rheumatoid Arthritis + Sickle Cell Disease & Exercise + Kids Vision - Alabama News Network

MEDICAL BREAKTHROUGHS: Dangers of Rheumatoid Arthritis + Sickle Cell Disease & Exercise + Kids Vision    Alabama News Network

MEDICAL BREAKTHROUGHS: Dangers of Rheumatoid Arthritis + Sickle Cell Disease & Exercise + Kids Vision - Alabama News Network

MEDICAL BREAKTHROUGHS: Dangers of Rheumatoid Arthritis + Sickle Cell Disease & Exercise + Kids Vision    Alabama News Network

One Size Does Not Always Fit All in Value Assessment - AJMC.com Managed Markets Network

One Size Does Not Always Fit All in Value Assessment    AJMC.com Managed Markets Network

Conventional Therapy Bests Tapered Therapy in Rheumatoid Arthritis - Rheumatology Network

Conventional Therapy Bests Tapered Therapy in Rheumatoid Arthritis    Rheumatology Network

Biologics Show Similar Efficacy in Older Patients as in Younger, No Matter When RA Begins - The Center for Biosimilars

Biologics Show Similar Efficacy in Older Patients as in Younger, No Matter When RA Begins    The Center for Biosimilars

Researchers split the 'AtoM' in search of a treatment for rheumatoid arthritis - EurekAlert

Researchers split the 'AtoM' in search of a treatment for rheumatoid arthritis    EurekAlert

FDA Approves Pfizer's Biosimilar, ABRILADA™ (adalimumab-afzb) for Multiple Inflammatory Conditions - Business Wire

FDA Approves Pfizer's Biosimilar, ABRILADA™ (adalimumab-afzb) for Multiple Inflammatory Conditions    Business Wire

Conventional Therapy Bests Tapered Therapy in Rheumatoid Arthritis - Rheumatology Network

Conventional Therapy Bests Tapered Therapy in Rheumatoid Arthritis    Rheumatology Network

Researchers split the 'AtoM' in search of a treatment for rheumatoid arthritis - EurekAlert

Researchers split the 'AtoM' in search of a treatment for rheumatoid arthritis    EurekAlert

Pfizer's Xeljanz gets EMA blood clots warning following FDA's similar move - FiercePharma

Pfizer's Xeljanz gets EMA blood clots warning following FDA's similar move    FiercePharma

Conventional Therapy Bests Tapered Therapy in Rheumatoid Arthritis - Rheumatology Network

Conventional Therapy Bests Tapered Therapy in Rheumatoid Arthritis    Rheumatology Network

Researchers split the 'AtoM' in search of a treatment for rheumatoid arthritis - EurekAlert

Researchers split the 'AtoM' in search of a treatment for rheumatoid arthritis    EurekAlert

WSU researchers weaponize nanoparticles to combat inflammatory diseases - BioWorld Online

WSU researchers weaponize nanoparticles to combat inflammatory diseases    BioWorld Online

Biologics Show Similar Efficacy in Older Patients as in Younger, No Matter When RA Begins - The Center for Biosimilars

Biologics Show Similar Efficacy in Older Patients as in Younger, No Matter When RA Begins    The Center for Biosimilars

Conventional Therapy Bests Tapered Therapy in Rheumatoid Arthritis - Rheumatology Network

Conventional Therapy Bests Tapered Therapy in Rheumatoid Arthritis    Rheumatology Network

Researchers split the 'AtoM' in search of a treatment for rheumatoid arthritis - EurekAlert

Researchers split the 'AtoM' in search of a treatment for rheumatoid arthritis    EurekAlert

Researchers split the 'AtoM' in search of a treatment for rheumatoid arthritis - EurekAlert

Researchers split the 'AtoM' in search of a treatment for rheumatoid arthritis    EurekAlert

Researchers split the 'AtoM' in search of a treatment for rheumatoid arthritis - EurekAlert

Researchers split the 'AtoM' in search of a treatment for rheumatoid arthritis    EurekAlert

Researchers split the 'AtoM' in search of a treatment for rheumatoid arthritis - EurekAlert

Researchers split the 'AtoM' in search of a treatment for rheumatoid arthritis    EurekAlert

Yoga and physical therapy as treatment for chronic lower back pain also improves sleep - Science Daily

Yoga and physical therapy as treatment for chronic lower back pain also improves sleep    Science Daily

Rheumatoid Arthritis Is No Bar to Cancer Immunotherapy - MedPage Today

Rheumatoid Arthritis Is No Bar to Cancer Immunotherapy    MedPage Today

Yoga and physical therapy as treatment for chronic lower back pain also improves sleep - Science Daily

Yoga and physical therapy as treatment for chronic lower back pain also improves sleep    Science Daily

WSU researchers weaponize nanoparticles to combat inflammatory diseases - BioWorld Online

WSU researchers weaponize nanoparticles to combat inflammatory diseases    BioWorld Online

Sarilumab as a Combination or Monotherapy Successfully Targets IL-6, Improves Symptoms in Patients With RA - AJMC.com Managed Markets Network

Sarilumab as a Combination or Monotherapy Successfully Targets IL-6, Improves Symptoms in Patients With RA    AJMC.com Managed Markets Network

Researchers split the 'AtoM' in search of a treatment for rheumatoid arthritis - EurekAlert

Researchers split the 'AtoM' in search of a treatment for rheumatoid arthritis    EurekAlert

Sandoz presents real-world data showing effectiveness of Erelzi® (etanercept-szzs) in rheumatic disease treatment - GlobeNewswire

Sandoz presents real-world data showing effectiveness of Erelzi® (etanercept-szzs) in rheumatic disease treatment    GlobeNewswire

New Etiology of Rheumatoid Arthritis Identified in the Gut Microbiome - Rheumatology Network

New Etiology of Rheumatoid Arthritis Identified in the Gut Microbiome    Rheumatology Network

Mallinckrodt Announces New Clinical Data Evaluating Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2019 American College of Rheumatology/Association of Rheumatology Professionals (ACR/ARP) Annual Meeting - Benzinga

Mallinckrodt Announces New Clinical Data Evaluating Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2019 American College of Rheumatology/Association of Rheumatology Professionals (ACR/ARP) Annual Meeting    Benzinga

Sarilumab as a Combination or Monotherapy Successfully Targets IL-6, Improves Symptoms in Patients With RA - AJMC.com Managed Markets Network

Sarilumab as a Combination or Monotherapy Successfully Targets IL-6, Improves Symptoms in Patients With RA    AJMC.com Managed Markets Network

Rheumatoid Arthritis Is No Bar to Cancer Immunotherapy - MedPage Today

Rheumatoid Arthritis Is No Bar to Cancer Immunotherapy    MedPage Today

Mallinckrodt Announces New Clinical Data Evaluating Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2019 American College of Rheumatology/Association of Rheumatology Professionals (ACR/ARP) Annual Meeting - BioSpace

Mallinckrodt Announces New Clinical Data Evaluating Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2019 American College of Rheumatology/Association of Rheumatology Professionals (ACR/ARP) Annual Meeting    BioSpace

Novel Vagus Nerve Stimulator Well-Tolerated in Drug Refractory Rheumatoid Arthritis - Neurology Advisor

Novel Vagus Nerve Stimulator Well-Tolerated in Drug Refractory Rheumatoid Arthritis    Neurology Advisor

World's first biopsy-driven RA trial finds tocilizumab superior to rituximab - Healio

World's first biopsy-driven RA trial finds tocilizumab superior to rituximab    Healio

Rheumatoid Arthritis Is No Bar to Cancer Immunotherapy - MedPage Today

Rheumatoid Arthritis Is No Bar to Cancer Immunotherapy    MedPage Today

Novel Vagus Nerve Stimulator Well-Tolerated in Drug Refractory Rheumatoid Arthritis - Neurology Advisor

Novel Vagus Nerve Stimulator Well-Tolerated in Drug Refractory Rheumatoid Arthritis    Neurology Advisor

More than 30% of PCPs fail to follow physical activity guidance for RA patients - Healio

More than 30% of PCPs fail to follow physical activity guidance for RA patients    Healio

Statement from Sarah Yim, M.D., acting director of the Office of Therapeutic Biologics and Biosimilars in the FDA's Center for Drug Evaluation and Research, on FDA's continued progress facilitating competition in the biologic marketplace with approval of 25th biosimilar product - Herald-Mail Media

Statement from Sarah Yim, M.D., acting director of the Office of Therapeutic Biologics and Biosimilars in the FDA's Center for Drug Evaluation and Research, on FDA's continued progress facilitating competition in the biologic marketplace with approval of 25th biosimilar product    Herald-Mail Media

Mallinckrodt Announces New Clinical Data Evaluating Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2019 American College of Rheumatology/Association of Rheumatology Professionals (ACR/ARP) Annual Meeting - Benzinga

Mallinckrodt Announces New Clinical Data Evaluating Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2019 American College of Rheumatology/Association of Rheumatology Professionals (ACR/ARP) Annual Meeting    Benzinga

Methotrexate Controls Joint Damage in Hand Osteoarthritis, Small Study Shows - Rheumatology Network

Methotrexate Controls Joint Damage in Hand Osteoarthritis, Small Study Shows    Rheumatology Network

Methotrexate Controls Joint Damage in Hand Osteoarthritis, Small Study Shows - Rheumatology Network

Methotrexate Controls Joint Damage in Hand Osteoarthritis, Small Study Shows    Rheumatology Network

Methotrexate Controls Joint Damage in Hand Osteoarthritis, Small Study Shows - Rheumatology Network

Methotrexate Controls Joint Damage in Hand Osteoarthritis, Small Study Shows    Rheumatology Network

Mallinckrodt Announces New Clinical Data Evaluating Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2019 American College of Rheumatology/Association of Rheumatology Professionals (ACR/ARP) Annual Meeting - BioSpace

Mallinckrodt Announces New Clinical Data Evaluating Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2019 American College of Rheumatology/Association of Rheumatology Professionals (ACR/ARP) Annual Meeting    BioSpace

Dose of medication more likely to put patients with pemphigus into remission: Findings may inform use of recent FDA-approved drug rituximab to better treat patients with pemphigus - Science Daily

Dose of medication more likely to put patients with pemphigus into remission: Findings may inform use of recent FDA-approved drug rituximab to better treat patients with pemphigus    Science Daily

Nothing but the Tooth: Considering antibiotics for dental care after joint replacements - The Providence Journal

Nothing but the Tooth: Considering antibiotics for dental care after joint replacements    The Providence Journal

West Valley graduate Jadyn Fraser wins title 'Miss Alaska Teen USA 2020' - webcenter11

West Valley graduate Jadyn Fraser wins title 'Miss Alaska Teen USA 2020'    webcenter11

New Etiology of Rheumatoid Arthritis Identified in the Gut Microbiome - Rheumatology Network

New Etiology of Rheumatoid Arthritis Identified in the Gut Microbiome    Rheumatology Network

Low clinical value in repeat latent tuberculosis tests in patients taking biologics - Healio

Low clinical value in repeat latent tuberculosis tests in patients taking biologics    Healio

Mallinckrodt Announces New Clinical Data Evaluating Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2019 American College of Rheumatology/Association of Rheumatology Professionals (ACR/ARP) Annual Meeting - Benzinga

Mallinckrodt Announces New Clinical Data Evaluating Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2019 American College of Rheumatology/Association of Rheumatology Professionals (ACR/ARP) Annual Meeting    Benzinga

Roche’s Gazyva (obinutuzumab), in combination with standard of care, more than doubles the percentage of lupus nephritis patients achieving complete renal response, compared to standard of care alone - Yahoo Finance

Roche’s Gazyva (obinutuzumab), in combination with standard of care, more than doubles the percentage of lupus nephritis patients achieving complete renal response, compared to standard of care alone    Yahoo Finance

Sandoz presents real-world data showing effectiveness of Erelzi® (etanercept-szzs) in rheumatic disease treatment - Yahoo Finance

Sandoz presents real-world data showing effectiveness of Erelzi® (etanercept-szzs) in rheumatic disease treatment    Yahoo Finance

Pfizer (PFE) Reports Results of Phase 3 Study for XELJANZ (tofacitinib) in Juvenile Idiopathic Arthritis - StreetInsider.com

Pfizer (PFE) Reports Results of Phase 3 Study for XELJANZ (tofacitinib) in Juvenile Idiopathic Arthritis    StreetInsider.com

Novel Vagus Nerve Stimulator Well-Tolerated in Drug Refractory Rheumatoid Arthritis - Neurology Advisor

Novel Vagus Nerve Stimulator Well-Tolerated in Drug Refractory Rheumatoid Arthritis    Neurology Advisor

Trio Health Reports on Outpatient Costs for Individuals with Rheumatoid Arthritis (RA) Treated in the US Community Practices - PRNewswire

Trio Health Reports on Outpatient Costs for Individuals with Rheumatoid Arthritis (RA) Treated in the US Community Practices    PRNewswire

Foot MRI Unnecessary for Predicting RA in Clinically Suspect Arthralgia - Rheumatology Advisor

Foot MRI Unnecessary for Predicting RA in Clinically Suspect Arthralgia    Rheumatology Advisor

Magenta Therapeutics Presents First Immune Reset Results with Antibody-Drug Conjugate Across Multiple Autoimmune Diseases at ACR | Antibodies | News Channels - PipelineReview.com

Magenta Therapeutics Presents First Immune Reset Results with Antibody-Drug Conjugate Across Multiple Autoimmune Diseases at ACR | Antibodies | News Channels    PipelineReview.com

Global Ulcerative Colitis Immunology Drugs Market Insights 2019 – Janssen Biotech, Inc., Bristol-Myers Squibb Company, AbbVie Inc. - Globe News Reports

Global Ulcerative Colitis Immunology Drugs Market Insights 2019 – Janssen Biotech, Inc., Bristol-Myers Squibb Company, AbbVie Inc.    Globe News Reports

Pfizer Announces Results of Phase 3 Study for XELJANZ® (tofacitinib) in Juvenile Idiopathic Arthritis Ahead of Presentation at 2019 American College of Rheumatology/Association of Rheumatology Professionals Annual Meeting - Business Wire

Pfizer Announces Results of Phase 3 Study for XELJANZ® (tofacitinib) in Juvenile Idiopathic Arthritis Ahead of Presentation at 2019 American College of Rheumatology/Association of Rheumatology Professionals Annual Meeting    Business Wire

New Positive Data for RINVOQ™ (upadacitinib) on Signs and Symptoms in Patients with Ankylosing Spondylitis Presented at 2019 ACR/ARP Annual Meeting - PRNewswire

New Positive Data for RINVOQ™ (upadacitinib) on Signs and Symptoms in Patients with Ankylosing Spondylitis Presented at 2019 ACR/ARP Annual Meeting    PRNewswire

Sandoz presents real-world data showing effectiveness of Erelzi® (etanercept-szzs) in rheumatic disease treatment - GlobeNewswire

Sandoz presents real-world data showing effectiveness of Erelzi® (etanercept-szzs) in rheumatic disease treatment    GlobeNewswire

Roche's Gazyva (obinutuzumab), in combination with standard of care, more than doubles the percentage of lupus nephritis patients achieving complete renal response, compared to standard of care alone - GlobeNewswire

Roche's Gazyva (obinutuzumab), in combination with standard of care, more than doubles the percentage of lupus nephritis patients achieving complete renal response, compared to standard of care alone    GlobeNewswire

City’s start-up gets Rs 1cr grant under Natl Biopharma Mission - Times of India

City’s start-up gets Rs 1cr grant under Natl Biopharma Mission    Times of India

Q&A with Abdul Abdellatif, MD: New Era for Gout Patients - MD Magazine

Q&A with Abdul Abdellatif, MD: New Era for Gout Patients    MD Magazine

New Positive Data for RINVOQ(TM) (upadacitinib) on Signs and Symptoms in Patients with Ankylosing Spondylitis Presented at 2019 ACR/ARP Annual Meeting - P&T Community

New Positive Data for RINVOQ(TM) (upadacitinib) on Signs and Symptoms in Patients with Ankylosing Spondylitis Presented at 2019 ACR/ARP Annual Meeting    P&T Community

Global TNF Inhibitors Market Growth Analysis, Forecasts to 2025 – Pfizer, Novartis, Boehringer Ingelheim, Amgen, BioPharma, Mochida Pharmaceutical, Hanall - Globe News Reports

Global TNF Inhibitors Market Growth Analysis, Forecasts to 2025 – Pfizer, Novartis, Boehringer Ingelheim, Amgen, BioPharma, Mochida Pharmaceutical, Hanall    Globe News Reports

Trio Health Reports on Outpatient Costs for Individuals with Rheumatoid Arthritis (RA) Treated in the U.S. Community Practices - P&T Community

Trio Health Reports on Outpatient Costs for Individuals with Rheumatoid Arthritis (RA) Treated in the U.S. Community Practices    P&T Community

Immune Checkpoints Viable in Cancer Patients With RA - Medscape

Immune Checkpoints Viable in Cancer Patients With RA    Medscape

Global Rheumatoid Arthritis Drugs Market Review 2016-2018 & Forecast 2019-2025 - ResearchAndMarkets.com - Business Wire

Global Rheumatoid Arthritis Drugs Market Review 2016-2018 & Forecast 2019-2025 - ResearchAndMarkets.com    Business Wire

Roche’s Gazyva (obinutuzumab), in combination with standard of care, more than doubles the percentage of lupus nephritis patients achieving complete renal response, compared to standard of care alone - Yahoo Finance

Roche’s Gazyva (obinutuzumab), in combination with standard of care, more than doubles the percentage of lupus nephritis patients achieving complete renal response, compared to standard of care alone    Yahoo Finance

Sandoz presents real-world data showing effectiveness of Erelzi® (etanercept-szzs) in rheumatic disease treatment - Yahoo Finance

Sandoz presents real-world data showing effectiveness of Erelzi® (etanercept-szzs) in rheumatic disease treatment    Yahoo Finance

Pfizer (PFE) Reports Results of Phase 3 Study for XELJANZ (tofacitinib) in Juvenile Idiopathic Arthritis - StreetInsider.com

Pfizer (PFE) Reports Results of Phase 3 Study for XELJANZ (tofacitinib) in Juvenile Idiopathic Arthritis    StreetInsider.com

Magenta Therapeutics Presents First Immune Reset Results with Antibody-Drug Conjugate Across Multiple Autoimmune Diseases at ACR | Antibodies | News Channels - PipelineReview.com

Magenta Therapeutics Presents First Immune Reset Results with Antibody-Drug Conjugate Across Multiple Autoimmune Diseases at ACR | Antibodies | News Channels    PipelineReview.com